Table 3.
Estimated Total Direct and Indirect Lifetime Costs for Newly Diagnosed Valley Fever Cases in Arizona in 2019
| Costs | Patients (N = 10 359) | Avg Per Person Lifetime Cost | Total Lifetime Cost for Arizona |
|---|---|---|---|
| Direct Costs | |||
| Primary uncomplicated pneumonia | 8805 | $23 192 | $204 209 262 |
| Chronic pneumonia | 259 | $130 033 | $33 675 245 |
| Disseminated infection | 259 | $1 262 414 | $326 933 779 |
| Other pulmonary changes: pulmonary nodules | 725 | $100 768 | $73 069 735 |
| Other pulmonary changes: pulmonary cavities | 311 | $106 171 | $32 994 839 |
| Indirect Costs | |||
| Primary uncomplicated pneumonia | 8805 | $1299 | $11 437 890 |
| Chronic pneumonia | 259 | $41 113 | $10 647 198 |
| Disseminated infection | 259 | $137 379 | $35 577 694 |
| Other pulmonary changes: pulmonary nodules | 725 | $7471 | $5 417 535 |
| Other pulmonary changes: pulmonary cavities | 311 | $7 471 | $2 321 801 |
| Total Costs of Valley Fever | |||
| Direct costs | $670 882 860 | ||
| Indirect costs | $65 402 119 | ||
| Work loss | $22 876 440 | ||
| Mortality | $42 525 679 | ||
| Total direct + indirect costs | $71 077 | $736 284 978 |
Abbreviations: Avg, average.